1 July 2002 in Journal of Hepatology
9 April 2013 in Journal of Personality Assessment
The accuracy of the Life Orientation Test–Revised (LOT–R) in measuring dispositional optimism was investigated applying item response theory (IRT). The study was conducted on a sample of 484 university students (62% males, M age = 22.79 years, SD = 5.63). After testing the 1-factor structure of the scale, IRT was applied to evaluate the functioning of the LOT–R along the pessimism–optimism continuum. Item parameter estimates and the test information function showed that each item and the global scale satisfactorily measured the latent trait. Referring to the IRT estimated trait levels, the validity of the LOT–R was studied examining the relationships between dispositional optimism and psychological well-being, sense of mastery, and sense of coherence. Overall findings based on IRT analyses provide evidence of the accuracy of the LOT–R and suggest possible modifications of the scale to improve the assessment of dispositional optimism.
1 March 2001 in Hepatology
Activated hepatic stellate cells (HSC) regulate the liver “wound‐healing” response through expression of chemokines, including monocyte chemoattractant protein‐1 (MCP‐1), which participate in the formation of the inflammatory infiltrate during liver injury. Cyclooxygenase (COX) catalyzes the conversion of arachidonic acid into prostaglandins, which may contribute to the inflammatory response. In this study, we investigated the effects of COX inhibitors on the expression of MCP‐1 in cultured HSC. Pretreatment of HSC with nonspecific COX inhibitors such as indomethacin or ibuprofen markedly reduced the expression of MCP‐1 caused by exposure to tumor necrosis factor α (TNF‐α) or interleukin‐1α (IL‐1α). NS‐398, a specific COX‐2 inhibitor, also resulted in a dose‐dependent inhibition of MCP‐1 gene and protein expression. These effects were dependent on reduced MCP‐1 transcription, as established using a reporter plasmid. In contrast, the up‐regulation of MCP‐1 expression caused by interferon gamma (IFN‐γ) was not sensitive to COX inhibitors. Quiescent HSC did not show detectable expression of COX‐2, which became evident after activation in culture, and while TNF‐α and IL‐1α markedly increased the expression of COX‐2, IFN‐γ did not have any effects. Pretreatment of HSC with the stable cyclic adenosine monophosphate (cAMP) analog, 8‐bromo cAMP, reverted the effects of the COX‐2 inhibitor, but not of a nuclear factor‐κB (NF‐κB) inhibitor, demonstrating that prostaglandins modulate MCP‐1 expression via production of cAMP. On the other hand, the action of NF‐κB inhibitors was negligible in IFN‐γ—stimulated cells. These findings indicate that cross‐talk between cytokines and a prostaglandin‐cAMP pathway differentially regulates the proinflammatory potential of HSC, contributing to the modulation of liver tissue inflammation.
1 July 2004 in American Journal of Physiology-Gastrointestinal and Liver Physiology
Hepatic stellate cells (HSC) coordinate the liver wound-healing response through secretion of several cytokines and chemokines, including CCL2 (formerly known as monocyte chemoattractant protein-1). In this study, we evaluated the role of different proteins of the MAPK family (ERK, p38MAPK, and JNK) in the regulation of CCL2 expression by HSC, as an index of their proinflammatory activity. Several mediators activated all three MAPK, including TNF, IL-1, and PDGF. To assess the relative role of the different MAPKs, specific pharmacological inhibitors were used; namely, SB203580 (p38MAPK), SP600125 (JNK), and PD98059 (MEK/ERK). The efficacy and specificity of the different inhibitors in our cellular system were verified analyzing the enzymatic activity of the different MAPKs using in vitro kinase assays and/or testing the inhibition of phosphorylation of downstream substrates. SB203580 and SP600125 dose-dependently inhibited CCL2 secretion and gene expression induced by IL-1 or TNF. In contrast, inhibition of ERK did not affect the upregulation of CCL2 induced by the two cytokines. Finally, activin A was also found to stimulate CCL2 expression and to activate ERK, JNK, p38, and their downstream targets. Unlike in cells exposed to proinflammatory cytokines, all three MAPKs were required to induce CCL2 secretion in response to activin. We conclude that members of the MAPK family differentially regulate cytokine-induced chemokine expression in human HSC.